Open access
Oct 2026
Cardiac Reverse Remodeling and Clinical Outcomes Following Angiotensin Receptor-Neprilysin Inhibitor Therapy in Heart Failure With Reduced Ejection Fraction.
BACKGROUND Cardiac reverse remodeling and associated clinical outcomes following angiotensin receptor-neprilysin inhibitor (ARNI) therapy in patients with heart failure (HF) with reduced ejection fraction (EF) remain unclear. We investigated differences in 1-year echocardiographic response after ARNI therapy and predic...
N. Y. Bae, S. Kwak, C. Park et al.
· Journal of the American Hear... · 0 citations